LU79937A1 - Neue 1-acyl-2-cyanaziridine,verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen - Google Patents
Neue 1-acyl-2-cyanaziridine,verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen Download PDFInfo
- Publication number
- LU79937A1 LU79937A1 LU79937A LU79937A LU79937A1 LU 79937 A1 LU79937 A1 LU 79937A1 LU 79937 A LU79937 A LU 79937A LU 79937 A LU79937 A LU 79937A LU 79937 A1 LU79937 A1 LU 79937A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- cyanaziridine
- acyl
- compounds
- new
- production
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
- C07D203/18—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/22—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C07D203/24—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F42—AMMUNITION; BLASTING
- F42B—EXPLOSIVE CHARGES, e.g. FOR BLASTING, FIREWORKS, AMMUNITION
- F42B3/00—Blasting cartridges, i.e. case and explosive
- F42B3/087—Flexible or deformable blasting cartridges, e.g. bags or hoses for slurries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19772731264 DE2731264A1 (de) | 1977-07-11 | 1977-07-11 | Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
LU79937A1 true LU79937A1 (de) | 1980-02-14 |
Family
ID=6013651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU79937A LU79937A1 (de) | 1977-07-11 | 1978-07-07 | Neue 1-acyl-2-cyanaziridine,verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen |
Country Status (26)
Country | Link |
---|---|
US (1) | US4267174A (de) |
JP (1) | JPS5436254A (de) |
AT (1) | AT356663B (de) |
AU (2) | AU519219B2 (de) |
BE (1) | BE868796A (de) |
CA (1) | CA1086309A (de) |
CS (1) | CS208656B2 (de) |
DD (1) | DD137710A5 (de) |
DE (1) | DE2731264A1 (de) |
DK (1) | DK306978A (de) |
ES (1) | ES471512A1 (de) |
FI (1) | FI782157A (de) |
FR (1) | FR2397403A1 (de) |
GB (1) | GB1594079A (de) |
HU (1) | HU179428B (de) |
IL (1) | IL55109A (de) |
IT (1) | IT1096910B (de) |
LU (1) | LU79937A1 (de) |
NL (1) | NL7807276A (de) |
NO (1) | NO782399L (de) |
NZ (1) | NZ187794A (de) |
PL (1) | PL126639B1 (de) |
PT (1) | PT68263A (de) |
SE (1) | SE7807642L (de) |
SU (1) | SU1077565A3 (de) |
ZA (1) | ZA783829B (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2906603A1 (de) | 1979-02-21 | 1980-09-04 | Boehringer Mannheim Gmbh | N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel |
US4393000A (en) * | 1979-12-12 | 1983-07-12 | Mitsui Toatsu Chemicals, Inc. | Cyclization process for producing aziridine-2-carboxylic acid or its salts |
US4925835A (en) * | 1986-05-01 | 1990-05-15 | Sloan-Kettering Institute For Cancer Research | Aziridinyl putrescine containing compositions and their uses in treating prostate cancer |
US6982263B2 (en) * | 2001-06-08 | 2006-01-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Nitriles useful as reversible inhibitors of cysteine proteases |
US8293751B2 (en) | 2003-01-14 | 2012-10-23 | Arena Pharmaceuticals, Inc. | 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
EP1606282B1 (de) * | 2003-02-24 | 2008-11-12 | Arena Pharmaceuticals, Inc. | Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus |
AR045047A1 (es) * | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
DK1756084T3 (da) * | 2004-06-04 | 2009-03-23 | Arena Pharm Inc | Substituerede aryl- og heteroarylderivater som modulatorer af metabolisme og forebyggelse og behandling af forstyrrelser beslægtet dermed |
DOP2006000010A (es) | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
MY148521A (en) * | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
NZ565898A (en) * | 2005-09-16 | 2010-07-30 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
TW200811140A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
TW200811147A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
JP5856980B2 (ja) | 2010-01-27 | 2016-02-10 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス |
KR101871011B1 (ko) | 2010-09-22 | 2018-06-25 | 아레나 파마슈티칼스, 인크. | Gpr119 수용체의 조절제 및 그와 관련된 장애의 치료 |
UA126268C2 (uk) | 2015-01-06 | 2022-09-14 | Арена Фармасьютікалз, Інк. | СПОСОБИ ЛІКУВАННЯ СТАНІВ, ПОВ'ЯЗАНИХ З РЕЦЕПТОРОМ S1P<sub>1 </sub> |
EA201890096A1 (ru) | 2015-06-22 | 2018-08-31 | Арена Фармасьютикалз, Инк. | КРИСТАЛЛИЧЕСКАЯ L-АРГИНИНОВАЯ СОЛЬ (R)-2-(7-(4-ЦИКЛОПЕНТИЛ-3-(ТРИФТОРМЕТИЛ)БЕНЗИЛОКСИ)-1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ (СОЕДИНЕНИЯ 1) ДЛЯ ПРИМЕНЕНИЯ ПРИ РАССТРОЙСТВАХ, СВЯЗАННЫХ С S1P-РЕЦЕПТОРОМ |
US11534424B2 (en) | 2017-02-16 | 2022-12-27 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
LV15518A (lv) * | 2019-02-18 | 2020-08-20 | Latvijas Organiskās Sintēzes Institūts | Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze |
US20230039836A1 (en) * | 2020-01-10 | 2023-02-09 | Uniwersytet Jagiellonski | Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use |
WO2021141507A1 (en) * | 2020-01-10 | 2021-07-15 | Uniwersytet Jagielloński | Aromatic sulphonamides derivatives that inhibits pdi a3, their synthesis and use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD110492A1 (de) * | 1974-03-21 | 1974-12-20 | ||
JPS5932772B2 (ja) * | 1974-09-21 | 1984-08-10 | 旭光学工業 (株) | 照射光走査装置 |
DE2528460A1 (de) * | 1975-06-26 | 1977-01-13 | Boehringer Mannheim Gmbh | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans |
-
1977
- 1977-07-11 DE DE19772731264 patent/DE2731264A1/de not_active Withdrawn
-
1978
- 1978-05-17 GB GB20099/78A patent/GB1594079A/en not_active Expired
- 1978-06-16 US US05/916,389 patent/US4267174A/en not_active Expired - Lifetime
- 1978-07-04 SU SU782631500A patent/SU1077565A3/ru active
- 1978-07-04 FI FI782157A patent/FI782157A/fi not_active Application Discontinuation
- 1978-07-04 ZA ZA783829A patent/ZA783829B/xx unknown
- 1978-07-04 CA CA306,740A patent/CA1086309A/en not_active Expired
- 1978-07-05 PL PL1978208195A patent/PL126639B1/pl unknown
- 1978-07-05 NL NL7807276A patent/NL7807276A/xx not_active Application Discontinuation
- 1978-07-06 ES ES471512A patent/ES471512A1/es not_active Expired
- 1978-07-06 DD DD78206567A patent/DD137710A5/de unknown
- 1978-07-06 BE BE189121A patent/BE868796A/xx unknown
- 1978-07-06 AU AU37826/78A patent/AU519219B2/en not_active Expired
- 1978-07-06 AU AU37826/78A patent/AU3782678A/en active Granted
- 1978-07-07 LU LU79937A patent/LU79937A1/de unknown
- 1978-07-07 SE SE7807642A patent/SE7807642L/xx unknown
- 1978-07-07 NZ NZ187794A patent/NZ187794A/xx unknown
- 1978-07-07 IT IT25474/78A patent/IT1096910B/it active
- 1978-07-07 PT PT68263A patent/PT68263A/de unknown
- 1978-07-07 DK DK783069A patent/DK306978A/da not_active Application Discontinuation
- 1978-07-07 CS CS784544A patent/CS208656B2/cs unknown
- 1978-07-09 IL IL55109A patent/IL55109A/xx unknown
- 1978-07-10 AT AT496478A patent/AT356663B/de not_active IP Right Cessation
- 1978-07-10 FR FR7820468A patent/FR2397403A1/fr not_active Withdrawn
- 1978-07-10 NO NO782399A patent/NO782399L/no unknown
- 1978-07-10 HU HU78BO1723A patent/HU179428B/hu unknown
- 1978-07-11 JP JP8364578A patent/JPS5436254A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AT356663B (de) | 1980-05-12 |
CS208656B2 (en) | 1981-09-15 |
SE7807642L (sv) | 1979-03-14 |
DE2731264A1 (de) | 1979-02-01 |
AU519219B2 (en) | 1981-11-19 |
BE868796A (fr) | 1979-01-08 |
AU3782578A (en) | 1980-01-10 |
AU3782678A (en) | 1980-01-10 |
NZ187794A (en) | 1980-05-08 |
ES471512A1 (es) | 1979-10-01 |
PL208195A1 (de) | 1980-03-24 |
HU179428B (en) | 1982-10-28 |
GB1594079A (en) | 1981-07-30 |
CA1086309A (en) | 1980-09-23 |
DK306978A (da) | 1979-01-12 |
SU1077565A3 (ru) | 1984-02-29 |
FR2397403A1 (fr) | 1979-02-09 |
DD137710A5 (de) | 1979-09-19 |
NO782399L (no) | 1979-01-12 |
IL55109A0 (en) | 1978-09-29 |
IT7825474A0 (it) | 1978-07-07 |
NL7807276A (nl) | 1979-01-15 |
ZA783829B (en) | 1980-03-26 |
PL126639B1 (en) | 1983-08-31 |
ATA496478A (de) | 1979-10-15 |
PT68263A (de) | 1978-08-01 |
IL55109A (en) | 1982-07-30 |
US4267174A (en) | 1981-05-12 |
IT1096910B (it) | 1985-08-26 |
JPS5436254A (en) | 1979-03-16 |
FI782157A (fi) | 1979-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU79937A1 (de) | Neue 1-acyl-2-cyanaziridine,verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen | |
ATE6934T1 (de) | Sulfonylharnstoffe, verfahren zu ihrer herstellung und pharmazeutische praeparate enthaltend diese verbindungen. | |
PT82789B (de) | Neue 2-arylmidazole diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
PT80476B (de) | Neue aminotetralinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
DE3680877D1 (de) | Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3881950D1 (de) | Azabicyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
DD133801A5 (de) | Neue aminopropanolderivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
DE3777122D1 (de) | Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
PT66756A (de) | 2-brom-6-fluor-n-2-imidazolidinylidenbenzamin,dessen saeureadditionssalze,diese enthaltende arzneimittel und verfahren zu deren herstellung | |
DE3675714D1 (de) | Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
PT68404A (de) | 4-hydroxy-2-benzimidazolinon-derivate verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel | |
DE3767894D1 (de) | 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung. | |
ATE4206T1 (de) | Neue morpholinderivate, verfahren zu deren herstellung, diese derivate enthaltende pharmazeutische praeparate. | |
DE59003716D1 (de) | Neue diphosphonsäurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. | |
LU80659A1 (de) | Neue pyrido-pyrimidine,verfahren zu ihrer herstellung und diese verbindungen enthaltenden arzneimittel | |
PT65544A (de) | Substituierte sulfoximide,verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
PT75626B (de) | Aminooxazolylverbindungen verfahren zu ihrer herstellung pharmazeutische praeparate welche diese verbindungen enthalten | |
PT68656A (de) | Neue 4-phenyl-thieno-/2,3-c/-piperidine verfahren zu ihrerherstellung und diese enthaltende pharmazeutische zusammensetzungen | |
PT65482A (de) | Neue 2,4-diamino-5-benzypyrimidine,verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
PT67869B (de) | Thiobenzylpyrimidine verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
PT66275A (de) | Neue aziridin-derivative,verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel | |
LU84492A1 (de) | Cumarin-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate | |
ATE9470T1 (de) | Indolessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel. | |
PT73408B (de) | Neue lactame verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
LU80259A1 (de) | 4-alkyl-3,5-dioxo-pyrazolidinyl-derivate,verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische zubereitungen |